ORCHEZ Trademark

Trademark Overview

On Monday, May 17, 2021, a trademark application was filed for ORCHEZ with the United States Patent and Trademark Office. The USPTO has given the ORCHEZ trademark a serial number of 90715578. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, August 5, 2025. This trademark is owned by Teva Pharmaceuticals USA, Inc.. The ORCHEZ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents affecting circulatory systems; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting urogenital organs; Pharmaceutical agents affecting peripheral nervous system
orchez

General Information

Serial Number90715578
Word MarkORCHEZ
Filing DateMonday, May 17, 2021
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, August 5, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 12, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents affecting circulatory systems; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting urogenital organs; Pharmaceutical agents affecting peripheral nervous system

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, August 14, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTeva Pharmaceuticals USA, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressParsippany, NJ 07054
Party NameTeva Pharmaceuticals USA, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressParsippany, NJ 07054

Trademark Events

Event DateEvent Description
Thursday, May 20, 2021NEW APPLICATION ENTERED
Friday, November 12, 2021NON-FINAL ACTION WRITTEN
Saturday, August 14, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 12, 2021ASSIGNED TO EXAMINER
Friday, November 12, 2021NON-FINAL ACTION E-MAILED
Friday, November 12, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 12, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 12, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 13, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, May 9, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, May 9, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, May 9, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, May 9, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, June 6, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 22, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 12, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, February 22, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, February 22, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, February 22, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 12, 2022PUBLISHED FOR OPPOSITION
Tuesday, September 6, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, February 22, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, March 6, 2023SOU TEAS EXTENSION RECEIVED
Monday, March 6, 2023SOU EXTENSION 1 FILED
Monday, March 6, 2023SOU EXTENSION 1 GRANTED
Wednesday, March 8, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 1, 2023SOU TEAS EXTENSION RECEIVED
Friday, March 1, 2024SOU TEAS EXTENSION RECEIVED
Friday, September 1, 2023SOU EXTENSION 2 FILED
Friday, September 1, 2023SOU EXTENSION 2 GRANTED
Tuesday, September 5, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 1, 2024SOU EXTENSION 3 FILED
Friday, March 1, 2024SOU EXTENSION 3 GRANTED
Saturday, March 2, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 7, 2024ABANDONMENT - NO USE STATEMENT FILED
Tuesday, October 15, 2024TEAS PETITION TO REVIVE RECEIVED
Tuesday, October 15, 2024NOTICE OF REVIVAL - E-MAILED
Tuesday, October 15, 2024PETITION TO REVIVE-GRANTED
Thursday, June 26, 2025NOTICE OF ALLOWANCE CANCELLED
Thursday, June 26, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, June 26, 2025NEW NOA TO ISSUE
Tuesday, August 5, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, October 7, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

orchez pharmaceutical agents affecting treatment preparations bone organs disorders system diseases